2,908 followers
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…
471 followers
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…
251 followers
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…
74 followers
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…
6,772 followers
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…
1,973 followers
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…
101 followers
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…
1,413 followers
RT @ClinRheumatol: Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis…
6,772 followers
Long-term use of stable dose TNF-α inhibitor did not deteriorate atherogenic lipid profile in axial #Spondyloarthritis Read more: https://t.co/eGJ24OSo5h https://t.co/WD3RTZBXJ9